Articles

Videos

Podcasts

Clinical

The norepinephrine reuptake inhibitor indicated for patients aged age 6 to 17 years recently received FDA approval.

Viloxazine Is a New Option to Treat ADHD in Children

Methylphenidate hydrochloride extended-release tablets are indicated for the treatment of ADHD.

New Generic Methylphenidate Hydrochloride Tablets Available on the Market

The diagnosis and treatment of attention deficit hyperactivity disorder (ADHD) in children and teens can be a complex and unique challenge for providers.

Diagnosing ADHD in Children and Teens Following a Failure in First-line Medications

At the 2020 Virtual Conference on Pediatric Health Care, Dawn Garzon Maaks, discussed important elements in the diagnosis and treatment of tics in children with ADHD.
 

The Treatment of Tics in Children with ADHD

How did switching from name brand to generic cause a child’s death?

Monday Pharmaceutical Mystery: June 1

Generic products featured in the April 2020 issue.

Generic Products (April 2020)

Careful treatment selection can prevent lifelong and serious complications from these medications. 

Antipsychotics for Children With ADHD Should Be a Last Resort

ADHD is correlated with lower health-related quality of life that starts in childhood and can persist into adulthood.

Study Finds Children with ADHD are Less Physically Active

Studying individuals’ genomes can help influence how different medications work for a patient, avoid harmful adverse drug reactions, and allow scientists to develop personalized medicines for patients with a wide range of diseases and disorders.

Pharmacogenomics: The Future of ADHD Treatment Options

Why is a woman being prescribed phentermine for ADHD? 